Erythropoietin Terminated Phase 2 Trials for Aging / Anemias Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00104169Idiopathic Anemia of Aging (IAA)
NCT00210626Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
NCT00240734Treatment of Anemia in Diabetic Subjects With CKD